Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898321 | PMC |
http://dx.doi.org/10.1007/s00115-022-01413-z | DOI Listing |
J Clin Neurosci
December 2024
Departments of Neurosurgery, University of California, Los Angeles, CA, United States; Radiation Oncology, University of California, Los Angeles, CA, United States; Head and Neck Surgery, University of California, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, United States; Los Angeles Biomedical Research Institute, University of California, Los Angeles, CA, United States; Harbor-UCLA Medical Center, University of California, Los Angeles, CA, United States; David Geffen School of Medicine, University of California, Los Angeles, CA, United States. Electronic address:
Purpose: Stroke-like migraine attacks after radiation therapy (SMART) syndrome is characterized by migraines, seizures, and stroke-like symptoms following brain irradiation. Diagnosis consists of clinical signs, history of brain irradiation, and radiographic evaluation. The latency to onset varies widely among individual patients, ranging from 1 to 35 years.
View Article and Find Full Text PDFNeurology
January 2025
Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Ontario, Canada; and.
Pain Ther
December 2024
Los Angeles Headache Center, Los Angeles and San Diego, CA, USA.
Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies that target CGRP ligands or receptors, may cause a very rare side effect of reversible cerebral vasoconstriction syndrome (RCVS). This study is a case report of a patient who developed cerebral artery vasoconstriction documented on serial brain magnetic resonance angiography (MRA) scans without the typical manifestations of RCVS following galcanezumab loading dose. Case report: A 40-year-old female patient with high-frequency episodic migraine with visual aura on topiramate 100 mg/day developed transient numbness of the right upper and lower extremities and right face without headache and a normal neurological examination 10 min after a loading dose of galcanezumab, which resolved over the next 2 days.
View Article and Find Full Text PDFCureus
August 2024
Internal Medicine, Stockport National Health Service (NHS) Trust, Stockport, GBR.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!